We would've expected for most of the patients for the disease process to have progressed," said Dr. Robert P. Lanza, Advanced Cell chief scientific officer. "But what was the surprise was to see so much notable improvement in the vision. That was really unexpected."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.